Pentwater Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-15,552,000
| Closed | -$1.8B | – | 101 |
|
|
2023
Q3 | $1.8B | Buy |
15,552,000
+2,825,100
| +22% | +$327M | 9.67% | 3 |
|
|
2023
Q2 | $1.31B | Buy |
12,726,900
+6,626,900
| +109% | +$682M | 9.04% | 3 |
|
|
2023
Q1 | $666M | Buy |
6,100,000
+2,560,344
| +72% | +$279M | 6.44% | 2 |
|
|
2022
Q4 | $403M | Buy |
+3,539,656
| New | +$403M | 7.07% | 2 |
|
|
2015
Q4 | – | Sell |
-20,000
| Closed | -$396K | – | 100 |
|
|
2015
Q3 | $396K | Buy |
+20,000
| New | +$396K | ﹤0.01% | 81 |
|